Prescription Medicines and the Risk of Road Traffic Crashes: A French Registry-Based Study

English version České info

Background:
In recent decades, increased attention has been focused on the impact of disabilities and medicinal drug use on road safety. The aim of our study was to investigate the association between prescription medicines and the risk of road traffic crashes, and estimate the attributable fraction.

Methods and Findings:
We extracted and matched data from three French nationwide databases: the national health care insurance database, police reports, and the national police database of injurious crashes. Drivers identified by their national health care number involved in an injurious crash in France, between July 2005 and May 2008, were included in the study. Medicines were grouped according to the four risk levels of the French classification system (from 0 [no risk] to 3 [high risk]). We included 72,685 drivers involved in injurious crashes. Users of level 2 (odds ratio [OR] = 1.31 [1.24–1.40]) and level 3 (OR = 1.25 [1.12–1.40]) prescription medicines were at higher risk of being responsible for a crash. The association remained after adjustment for the presence of a long-term chronic disease. The fraction of road traffic crashes attributable to levels 2 and 3 medications was 3.3% [2.7%–3.9%]. A within-person case-crossover analysis showed that drivers were more likely to be exposed to level 3 medications on the crash day than on a control day, 30 days earlier (OR = 1.15 [1.05–1.27]).

Conclusion:
The use of prescription medicines is associated with a substantial number of road traffic crashes in France. In light of the results, warning messages appear to be relevant for level 2 and 3 medications and questionable for level 1 medications. A follow-up study is needed to evaluate the impact of the warning labeling system on road traffic crash prevention.

: Please see later in the article for the Editors' Summary

Vyšlo v časopise: Prescription Medicines and the Risk of Road Traffic Crashes: A French Registry-Based Study. PLoS Med 7(11): e32767. doi:10.1371/journal.pmed.1000366
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1000366

Souhrn

Zdroje

1. BarboneF

McMahonAD

DaveyPG

MorrisAD

ReidIC

1998 Association of road-traffic accidents with benzodiazepine use. Lancet 352 1331 1336

2. EngelandA

SkurtveitS

MorlandJ

2007 Risk of road traffic accidents associated with the prescription of drugs: a registry-based cohort study. Ann Epidemiol 17 597 602

3. GustavsenI

BramnessJG

SkurtveitS

EngelandA

NeutelI

2008 Road traffic accident risk related to prescriptions of the hypnotics zopiclone, zolpidem, flunitrazepam and nitrazepam. Sleep Med 9 818 822

4. HemmelgarnB

SuissaS

HuangA

BoivinJF

PinardG

1997 Benzodiazepine use and the risk of motor vehicle crash in the elderly. JAMA 278 27 31

5. HonkanenR

ErtamaL

LinnoilaM

AlhaA

LukkariI

1980 Role of drugs in traffic accidents. Br Med J 281 1309 1312

6. JickH

HunterJR

DinanBJ

MadsenS

StergachisA

1981 Sedating drugs and automobile accidents leading to hospitalization. Am J Public Health 71 1399 1400

7. LongoMC

HunterCE

LokanRJ

WhiteJM

WhiteMA

2000 The prevalence of alcohol, cannabinoids, benzodiazepines and stimulants amongst injured drivers and their role in driver culpability: part ii: the relationship between drug prevalence and drug concentration, and driver culpability. Accid Anal Prev 32 623 632

8. MovigKL

MathijssenMP

NagelPH

van EgmondT

de GierJJ

2004 Psychoactive substance use and the risk of motor vehicle accidents. Accid Anal Prev 36 631 636

9. MuraP

KintzP

LudesB

GaulierJM

MarquetP

2003 Comparison of the prevalence of alcohol, cannabis and other drugs between 900 injured drivers and 900 control subjects: results of a French collaborative study. Forensic Sci Int 133 79 85

10. NeutelCI

1995 Risk of traffic accident injury after a prescription for a benzodiazepine. Ann Epidemiol 5 239 244

11. NeutelI

1998 Benzodiazepine-related traffic accidents in young and elderly drivers. Hum Psychopharmacol Clin Exp 13 115 123

12. RayWA

FoughtRL

DeckerMD

1992 Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers. Am J Epidemiol 136 873 883

13. SkeggDC

RichardsSM

DollR

1979 Minor tranquillisers and road accidents. Br Med J 1 917 919

14. OrriolsL

SalmiLR

PhilipP

MooreN

DelormeB

2009 The impact of medicinal drugs on traffic safety: a systematic review of epidemiological studies. Pharmacoepidemiol Drug Saf 18 647 658

15. DrummerOH

GerostamoulosJ

BatzirisH

ChuM

CaplehornJ

2004 The involvement of drugs in drivers of motor vehicles killed in Australian road traffic crashes. Accid Anal Prev 36 239 248

16. LeveilleSG

BuchnerDM

KoepsellTD

McCloskeyLW

WolfME

1994 Psychoactive medications and injurious motor vehicle collisions involving older drivers. Epidemiology 5 591 598

17. BramnessJG

SkurtveitS

NeutelCI

MorlandJ

EngelandA

2008 minor increase in risk of road traffic accidents after prescriptions of antidepressants: a study of population registry data in Norway. J Clin Psychiatry e1 e5

18. European DRUID project (Driving Under the Influence of Drugs, Alcohol and Medicines) Available: www.druid-project.eu. Accessed 10 September 2010.

19. CastotA

DelormeB

the “Medicinal products and driving” Working Group Medicinal products and driving: how to assess the risk ? P2T Congress Marseille 2009 Abstract 481

20. WeillA

VallierN

SalavaneB

BourrelR

CaylaM

2006 Fréquence des affections de longue durée pour les bénéficiaires du Régime Général de l'Assurance maladie en 2004. Prat Organ Soins 37 173 188

21. JaroMA

1995 Probabilistic linkage of large public health data files. Stat Med 14 491 498

22. TrouessinG

AllaertFA

1997 FOIN: a nominative information occultation function. Stud Health Technol Inform 43 Pt A 196 200

23. IMS Health 2005-2008 Enquête Permanente sur la Prescription Médicale (EPPM). IMS Health

24. Arrêté du 8 août 2008 pris pour l'application de l'article R. 5121-139 du code de la santé publique et relatif à l'apposition d'un pictogramme sur le conditionnement extérieur de certains médicaments et produits

25. Working Group created by Afssaps: Christian Riché, Charles Caulin, Jacques Caron, Anne Chiffoleau, Christian Corbé, Bertrand Diquet, Alain Eschalier, Françoise Haramburu, Georges Lagier, Jean-Pierre Lépine, Michel Mallaret, Charles Mercier-Guyon, Louis Merle, Jean-Louis Montastruc, Pierre Philip, Francis Rodor 2009 Medicinal products and driving. Available: http://www.afssaps.fr, section Publications/Information in English. Accessed 10 September 2010.

26. RobertsonMD

DrummerOH

1994 Responsibility analysis: a methodology to study the effects of drugs in driving. Accid Anal Prev 26 243 247

27. LaumonB

GadegbekuB

MartinJL

BiechelerMB

2005 Cannabis intoxication and fatal road crashes in France: population based case-control study. BMJ 331 1371

28. RockhillB

NewmanB

WeinbergC

1998 Use and misuse of population attributable fractions. Am J Public Health 88 15 19

29. DiCiccioT

EfronB

1996 Bootstrap confidence intervals. Stat Sci 11 189 228

30. LlorcaJ

Delgado-RodriguezM

2000 A comparison of several procedures to estimate the confidence interval for attributable risk in case-control studies. Stat Med 19 1089 1099

31. MaclureM

1991 The case-crossover design: a method for studying transient effects on the risk of acute events. Am J Epidemiol 133 144 153

32. NoizeP

BazinF

DufouilC

Lechevallier-MichelN

AncelinML

2009 Comparison of health insurance claims and patient interviews in assessing drug use: data from the Three-City (3C) Study. Pharmacoepidemiol Drug Saf 18 310 319

33. SorockGS

QuigleyPA

RutledgeMK

TaylorJ

LuoX

2009 Central nervous system medication changes and falls in nursing home residents. Geriatr Nurs 30 334 340